Amy B Heimberger,
MD, FAANS, is the Jean Malnati Miller Professor of Neurological Surgery, Vice-Chair for Research in the Department of Neurological Surgery at Northwestern University and Scientific Director of The Malnati Brain Tumor Institute at the Robert H. Lurie Comprehensive Cancer Center. Her research program focuses on immune therapeutic strategies for patients with Central Nervous System (CNS) malignancies and she studies tumor-mediated mechanisms of immune suppression. She has been intricately involved in a wide variety of bench-to-bedside immune therapeutics, including those that were developed in her laboratory and arising from her own patents. She has expertise in the IND process and has been the PI of multiple clinical trials including the advocation for window-of-opportunity designs to evaluate the CNS tumor microenvironment.
Dr. Heimberger has been awarded the United States Presidential Early Career Award for Scientists and Engineers and she holds multiple National Institute of Health and foundation grants. She has served on a wide variety of NIH study sections and was the Chair of the Clinical Neuroimmunology and Brain Tumor Study Section. Dr. Heimberger’s research interests are complemented by her surgical specialization in awake craniotomies and mapping. She has been named by the US News and World Report as a Top Doc and is a member of the prestigious American Society of Clinical Investigators.